⌘K

Login Start Free

Home/Filings/4/0001209191-23-024939

4//SEC Filing

KIDRON NADAV 4

Accession 0001209191-23-024939

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 6:00 AM ET

Size

5.7 KB

Accession

0001209191-23-024939

Insider Transaction Report

Form 4

Period: 2023-04-17

ORAMED PHARMACEUTICALS INC.ORMP

DirectorPresident and CEO

Transactions

Award
Common Stock
2023-04-17+279,000→ 1,332,098 total

Holdings

Common Stock
(indirect: By wholly-owned corporation)
126,000

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 23,250 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001351779

Filing Metadata

Form type: 4
Filed: Apr 19, 8:00 PM ET
Accepted: Apr 20, 6:00 AM ET
Size: 5.7 KB

View on SEC.gov